Filip R, Chihu-Amparan L, Coman G, Silva-Sanchez J
Dept. of Microbiology, Faculty of Medicine, University of Medicine and Pharmacy Gr.T. Popa Iaşi.
Rev Med Chir Soc Med Nat Iasi. 2001 Jan-Mar;105(1):133-5.
To characterize the OMP profile and to study the possible interference with other resistance determinants.
16 non-typhoidic Salmonella strains, isolated in 1999 from stools of pediatric patients, were selected according to their resistance phenotype: resistance to Ampicillin (AMP), Amoxycillin/Clavulanic Acid (AMC), and third generation cephalosporins: Ceftriaxone (CRO) and Ceftazidime (CAZ). Identification and sensitivity testing were done by DADE MicroScan System. beta-Lactamases were characterized by isoelectric focusing (IEF) with preformed minigelss. OMPs were studied on membrane preparations on SDS-urea gels.
Isoelectric points: Majority of the isolates had the association 5.4 +/- 7.6 (3/16) or 5.4 + 8.2 (6/16). The second beta-lactamase has the capacity to hydrolyse CAZ. We found three different patterns of OMPs: I: 30, 29 and 25 kDa; II: 30, 26 and 24 kDa; III: 30 and 25 kDa. We couldn't find any correlation between the OMPs profile and resistance phenotype, showing that the beta-lactamase production is the only resistant determinant.
The study shows the high frequency of extended-spectrum beta-lactamases (ES beta LA) amongst the non-typhoidic Salmonella; association of TEM type and ES beta LA enzymes diminishes considerably the therapeutic resources: inhibitor associated combinations are non effective. In non-typhoidic Salmonella, porins seems to have no influence in co-modulation of resistance.
鉴定外膜蛋白(OMP)图谱,并研究其对其他耐药决定因素可能产生的干扰。
选取1999年从儿科患者粪便中分离出的16株非伤寒沙门氏菌菌株,根据其耐药表型进行选择:对氨苄西林(AMP)、阿莫西林/克拉维酸(AMC)以及第三代头孢菌素(头孢曲松(CRO)和头孢他啶(CAZ))耐药。通过DADE MicroScan系统进行鉴定和药敏试验。采用预制小凝胶等电聚焦(IEF)法对β-内酰胺酶进行鉴定。在SDS-尿素凝胶上的膜制剂上研究外膜蛋白。
等电点:大多数分离株的组合为5.4 +/- 7.6(3/16)或5.4 + 8.2(6/16)。第二种β-内酰胺酶具有水解头孢他啶的能力。我们发现了三种不同的外膜蛋白模式:I:30、29和25 kDa;II:30、26和24 kDa;III:30和25 kDa。我们未发现外膜蛋白图谱与耐药表型之间存在任何相关性,这表明β-内酰胺酶的产生是唯一的耐药决定因素。
该研究表明非伤寒沙门氏菌中广谱β-内酰胺酶(ESβLA)的频率很高;TEM型与ESβLA酶的联合显著减少了治疗资源:与抑制剂联合使用无效。在非伤寒沙门氏菌中,孔蛋白似乎对耐药的协同调节没有影响。